Home
NewsNewsFirst AI-powered egg-freezing program has been initiated by Sunfish with an intent to get rid of uncertainty within the fertility preservation space, offering personalised insights and higher success predictability for women.
Sunfish, a family-building software platform, is launching what it says is the first AI-powered egg-freezing programme in the fertility space. The goal of the program is to solve the uncertainty that comes with fertility preservation, from a lack of financial transparency to outcomes that are unknown and not guaranteed. Based on a patient’s biodata, Sunfish’s proprietary algorithm predicts the optimal amount of matured eggs that should be frozen as well as the cost of the cycle, positioning this AI-powered egg-freezing program as a data-driven solution.
“Sunfish is really focused on helping people to navigate the full fertility journey,” Angela Rastegar, co-founder and CEO of Sunfish, told Fierce Healthcare in an advanced interview. “Patients shouldn’t have to be an unpaid project manager for their own family planning.”
Sunfish also takes on risk. If a patient does not reach the number of retrieved eggs within the guaranteed budget, Sunfish will cover the cost of an additional cycle. One year of storage is included, with discounts for long-term storage options and lowest-price match guarantees on medication.
Sunfish works with IVF clinics, egg banks, fertility pharmacies, sperm banks and surrogacy agencies. All the clinics have been vetted, and members must be seen at those clinics to take advantage of Sunfish’s program. Its AI was built on cross-clinic historical datasets with over 2 million data points, such as biomarkers of egg and sperm donors and outcomes data. It was back-tested against 20,000 clinical cycles and, in thousands of randomised simulations, received 97% accuracy.
Rastegar was previously director of Northstar Fertility, which operates several surrogacy agency brands. She was frustrated that patients “weren’t getting logistical support, guidance, clear data and financial support.” She recalled how some patients had to sell their engagement rings to afford treatment or postpone buying a home.
Rastegar herself has gone through multiple rounds of egg freezing. “That was a really stressful process, not just financially, but what really surprised me was that I logistically, emotionally, became this full-time project manager trying to navigate my treatments,” she said.
Patients get a Sunfish dashboard with medically backed guidance, plus a human care coordinator and financial support. Members can also access prenatal vitamins, post-retrieval recovery, a nurse for injection support or mental health coaching. Sunfish offers 100% eligibility, regardless of age, diagnosis or insurance status. The package starts at $8,100, which includes all the clinical care components, though any insurance benefits may apply to components like lab work or medications. This comprehensive approach further strengthens the impact of the AI-powered egg-freezing program.
India's Central Drugs Standard Control Organisation has overhauled CDSCO IVF reagent sale norms, directing that all ART media, culture solutions, and reagents be supplied exclusively to clinics registered under the ART (Regulation) Act and Surrogacy (Regulation) Act. The move targets a growing unlicensed supply chain feeding an estimated 40–50% of India's 2,000-plus IVF centres.
Abu Dhabi University and FertiClinic Group have joined forces to establish the FertiClinic Reproductive Research Lab, an advanced reproductive research lab in Abu Dhabi housing IVF, andrology, and cryopreservation facilities. The partnership supports UAE national priorities, bridges academic and clinical expertise, and advances fertility innovation across the region.
NHS Kent and Medway has overhauled its fertility funding policy in a move that sees NHS cuts IVF access for thousands of patients. Effective 1 April 2026, the eligible age ceiling drops from 40 to 38, funded cycles fall from two to one, and embryo transfers are capped at two.
ASEAN's First Telemedicine IVF by Inspire IVF introduces a new era of remote fertility care. Combining AI technology with expert consultation, the platform enables global access, real-time monitoring, and personalised treatment planning, positioning Thailand as a leading hub for fertility services and advancing digital transformation in reproductive healthcare.
CSG.BIO has gone ahead with the acquisition of Hanabusa IVF, Asian Egg Bank, thereby making it a world leader in reproductive medicine and cutting-edge clinics with enhanced patient reach and advanced laboratory capabilities.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
